APA (7th ed.) Citation

Pfeifer, H., Cazzaniga, G., Velden, V. H. J. v. d., Cayuela, J. M., Schäfer, B., Spinelli, O., . . . Ottmann, O. G. (2019). Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia, 33(8), . https://doi.org/10.1038/s41375-019-0413-0

Chicago Style (17th ed.) Citation

Pfeifer, Heike, et al. "Standardisation and Consensus Guidelines for Minimal Residual Disease Assessment in Philadelphia-positive Acute Lymphoblastic Leukemia (Ph + ALL) by Real-time Quantitative Reverse Transcriptase PCR of E1a2 BCR-ABL1." Leukemia 33, no. 8 (2019). https://doi.org/10.1038/s41375-019-0413-0.

MLA (9th ed.) Citation

Pfeifer, Heike, et al. "Standardisation and Consensus Guidelines for Minimal Residual Disease Assessment in Philadelphia-positive Acute Lymphoblastic Leukemia (Ph + ALL) by Real-time Quantitative Reverse Transcriptase PCR of E1a2 BCR-ABL1." Leukemia, vol. 33, no. 8, 2019, https://doi.org/10.1038/s41375-019-0413-0.